Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy: A position statement from the AEPC Working …
JP Kaski, JAE Kammeraad, NA Blom… - Cardiology in the …, 2023 - cambridge.org
Sudden cardiac death is the most common mode of death during childhood and
adolescence in hypertrophic cardiomyopathy, and identifying those individuals at highest …
adolescence in hypertrophic cardiomyopathy, and identifying those individuals at highest …
A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy
Aims Sudden cardiac death (SCD) is the most common cause of death in children with
hypertrophic cardiomyopathy (HCM). The European Society of Cardiology (ESC) …
hypertrophic cardiomyopathy (HCM). The European Society of Cardiology (ESC) …
[HTML][HTML] Risk stratification in childhood hypertrophic cardiomyopathy
The true prevalence of hypertrophic cardiomyopathy (HCM) in childhood is unknown, but
population-based studies have reported an annual incidence between 0.24–0.47 per …
population-based studies have reported an annual incidence between 0.24–0.47 per …
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy
BJ Maron, P Spirito, MJ Ackerman, SA Casey… - Journal of the American …, 2013 - jacc.org
Objectives: The aim of this study was to determine the efficacy of implantable cardioverter-
defibrillators (ICDs) in children and adolescents with hypertrophic cardiomyopathy (HCM) …
defibrillators (ICDs) in children and adolescents with hypertrophic cardiomyopathy (HCM) …
Sudden cardiac death in childhood hypertrophic cardiomyopathy
K Thakkar, AR Karajgi, AM Kallamvalappil, C Avanthika… - Disease-a-Month, 2023 - Elsevier
The most prevalent cause of mortality in children with hypertrophic cardiomyopathy (HCM) is
sudden cardiac death (SCD), which happens more frequently than in adult patients. Risk …
sudden cardiac death (SCD), which happens more frequently than in adult patients. Risk …
Management of arrhythmias in hypertrophic cardiomyopathy
JT Stewart, WJ McKenna - Cardiovascular drugs and therapy, 1994 - Springer
In the management of hypertrophic cardiomyopathy the goals should be the control of
symptoms, and the identification and treatment of those at high risk. Arrhythmias, particularly …
symptoms, and the identification and treatment of those at high risk. Arrhythmias, particularly …
Hypertrophic cardiomyopathy in children, adolescents, and young adults associated with low cardiovascular mortality with contemporary management strategies
BJ Maron, EJ Rowin, SA Casey, JR Lesser… - Circulation, 2016 - Am Heart Assoc
Background—Youthful age has been considered the time of greatest risk for patients with
hypertrophic cardiomyopathy (HCM), largely because of the possibility of sudden death. The …
hypertrophic cardiomyopathy (HCM), largely because of the possibility of sudden death. The …
Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy
JP Kaski, MTT Esteban, M Lowe, S Sporton, P Rees… - Heart, 2007 - heart.bmj.com
METHODS Between 1993 and February 2006, 160 consecutively referred patients with
HCM (age⩽ 16 years) underwent clinical evaluation using 12-lead ECG, two-dimensional, M …
HCM (age⩽ 16 years) underwent clinical evaluation using 12-lead ECG, two-dimensional, M …
Risk stratification in pediatric hypertrophic cardiomyopathy: Insights for bridging the evidence gap?
SJ Nakano, SC Menon - Progress in pediatric cardiology, 2018 - Elsevier
Identification of children with hypertrophic cardiomyopathy (HCM) who are at high risk for
sudden cardiac death (SCD) remains challenging. Although a large number of risk factors …
sudden cardiac death (SCD) remains challenging. Although a large number of risk factors …
[HTML][HTML] Efficacy of implantable cardioverter–defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
BJ Maron, WK Shen, MS Link, AE Epstein… - … England Journal of …, 2000 - Mass Medical Soc
Background Hypertrophic cardiomyopathy is a genetic disease associated with a risk of
ventricular tachyarrhythmias and sudden death, especially in young patients. Methods We …
ventricular tachyarrhythmias and sudden death, especially in young patients. Methods We …
相关搜索
- implantable cardioverter hypertrophic cardiomyopathy
- management of arrhythmias hypertrophic cardiomyopathy
- implantable cardioverter sudden death
- sudden death hypertrophic cardiomyopathy
- young adults hypertrophic cardiomyopathy
- cardioverter defibrillators hypertrophic cardiomyopathy
- management strategies hypertrophic cardiomyopathy